Bristol Myers Squibb Investor

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.
Technology: Biotechnology, Health Care, Medical, Pharmaceutical
Industry: End-to-end Drug Development, Healthcare and Support
Headquarters: New York, New York, United States
Founded Date: 1887-01-01
Employees Number: 10001+
Funding Status: IPO
Number Of Exits: 9
Acquisitions Number: 9
Investors Number: 13
Total Funding: 80000000
Estimated Revenue: $1B to $10B
Last Funding Date: 2017-02-21
Last Funding Type: Post-IPO Equity

Visit Website
info@fernhealth.com
http://twitter.com/BMSNEWS
Register and Claim Ownership